Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Clinical trial NCT02778204 · COMPLETED
Trial details
- NCT number
- NCT02778204
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-05
- Primary completion
- 2019-09-06
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.